SkyePharma’s Asthma Drug Finally Approved in Europe – Equities.com

SkyePharma's Asthma Drug Finally Approved in Europe
Equities.com
LONDON – The asthma treatment Flutiform finally won the seal of the European Commission last week, more than 12 years after SkyePharma plc set its sights on what it thought would be the relatively straightforward development of a combination product
Small caps: Drug OK lifts SkyePharmaFinancial Times

all 2 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.